At IonOpticks, we’ve always believed that our best work happens when we collaborate. It’s through these partnerships that we’ve been able to create products that make a real difference in the scientific community, and our collaboration with Professor Tony Purcell from Monash University’s Biomedicine Discovery Institute is no exception.

Our work together on expanding Aurora Series accessibility to SCIEX users has been a solid, practical journey. It’s a testament to our shared commitment and passion for advancing scientific research. Focused on the development of the Aurora Series XS product – a bespoke chromatography solution specifically for the ZenoTOF 7600 system with the OptiFlow Turbo V ion source – the project effectively combines academic expertise with the practical needs of proteomics researchers.

Professor Purcell, a respected figure in immunopeptidomics, contributes not only his academic knowledge but also a keen understanding of the demands in highly sensitive LC-MS workflows. His unique blend of theory and practice has been key in refining the final product, ensuring it meets the real-world challenges researchers face.

In this short film, Professor Purcell offers insights into his lab’s work, showing us not just the technology he relies on but also the dedication and challenges his team navigates in their research. The film features both the newly developed Aurora Series XS and the Aurora Series CSI range – a staple in the Purcell Lab, known for significantly improving performance and integrating seamlessly with Bruker’s timsTOF instruments. It highlights Professor Purcell’s genuine endorsement based on his hands-on experience. In environments where efficiency and precision are paramount, reliability and reproducibility are everything. And Aurora Series columns provide both. They allow researchers like Tony to focus on their core work without the need for extensive training programs or fearing column changes mid-experiment.

The collaboration between IonOpticks and the Purcell Lab is more than a business venture; it’s a strategic alignment towards addressing key challenges in disease research. By combining academic and industrial expertise, we’ve created separation tools that are innovative and directly responsive to the needs of the research community.

Looking forward, the importance of collaborations like these becomes clear. They’re essential in pushing research boundaries and enabling new discoveries. For us, this project serves as the perfect model for product development. When designing and developing precision tools for the improvement of health outcomes for all, the involvement of academia in industry could never be more important.

Watch the full film.